TenNor raises $25M in series B round

Antibiotic play TenNor Therapeutics Ltd. (Suzhou, China) raised $25 million in a series B round led by Northern Light Venture Capital. Existing investors Frontline BioVentures, WuXi PharmaTech Healthcare, Oriza Venture Capital and Relativity Healthcare Fund also participated. ...